Article Archive - Page 49 of 63 - Business Chemistry

A capital market’s view on Industrial Biotechnology – proper valuation is the key for picking the right investment opportunities in stormy times

by | Sep 2009

Introduction Industrial biotechnology, also known as white biotechnology, is considered to be a revolutionary biotechnology field beside red and green biotechnology. After red (medicine) and green (agriculture), white biotechnology is now gaining momentum. With...

Assessment of thermal-stable polymer nanocomposite techniques by patent citation network analysis

by | Sep 2009

Nanocomposite material with new functions or properties superior to traditional composite materials opens a door to transform the way that material is currently applied. This study aims to provide 1) a systematic and quantitative method for obtaining global patent...

Feasibility of Active Ingredient (AI) development for new biocides in the EU

by | Sep 2009

Biocides usage covers a vast industrial area and the history of biocide and other antimicrobial agent usage in various forms and applications dates back centuries. While the emerging EU regulations (BPD, REACH and others) strive to increase the safety and the...

How to implement ‘access to medicine’ AND enhance economic performance: business model options for global access

by | Sep 2009

‘Access to medicine’ or ‘global access’ is at the core heart of corporate responsibility for pharmaceutical companies. Corporate responsibility, however, is not restricted to a philanthropic dimension (such as donations), which is often referred to as corporate...

Discussing challenges in the chemical industry for five years

by | Feb 2009

Five interesting years of the “Journal of Business Chemistry” (JoBC) have passed and many more are hopefully lying ahead of us, with the 6th volume currently in your hands. The JoBC is read throughout the world. Even though the `sectorial` focus seems quite narrow –...

« Older Entries

Next Entries »